R. Adinin

A phase I pharmacokinetic (PK) study of MBP-426, a novel liposome encapsulated oxaliplatin.

M. Beeram, A. Mita, K. Sankhala, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preliminary results from a phase II study of infusional 5-FU, leucovorin, and irinotecan (FOLFIRI) plus bevacizumab as first-line treatment for metastatic colorectal cancer (mCRC).

S. Kopetz, R. Wolff, J. Abbruzzese, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy

V. Valero, B. Esmaeli, S. Tu, 2003, Cancer.

Open label phase I study of MBP-426, a novel formulation of oxaliplatin, in patients with advanced or metastatic solid tumors.

C. Takimoto, M. Beeram, A. Phan, 2007 .

Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.

Jeffrey S. Morris, S. Kopetz, R. Wolff, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel.

K. Do, V. Valero, B. Esmaeli, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III study of docetaxel weekly (DW) versus every 3 weeks (D) in patients with metastatic breast cancer: Final results.

G. Hortobagyi, V. Valero, J. Mejia, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 3 study comparing the use of docetaxel on an every‐3‐week versus weekly schedule in the treatment of metastatic breast cancer

G. Hortobagyi, V. Valero, J. Mejia, 2008, Cancer.

Phase II study of pegylated liposomal doxorubicin in combination with gemcitabine in patients with metastatic breast cancer.

G. Hortobagyi, L. Pusztai, V. Valero, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I I S tudy o f P egylated L iposomal D oxorubicin i n Combination W ith G emcitabine i n P atients W ith M etastatic Breast C ancer

G. Hortobagyi, L. Pusztai, V. Valero, 2003 .

Phase 3 study comparing the use of docetaxel on an every‐3‐week versus weekly schedule in the treatment of metastatic breast cancer

G. Hortobagyi, V. Valero, J. Mejia, 2008, Cancer.